Skip to main content
Log in

Progesterone antagonists block the growth of experimental mammary tumors in G0/G1

  • Correspondence
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Michna H, Schneider MR, Nishino Y, El Etreby MF: Antitumor activity of the antiprogestins ZK 98.299 and RU 38.486 in hormone dependent rat and mouse mammary tumors: mechanistic studies. Breast Cancer Res Treat 14: 275–288, 1989

    PubMed  Google Scholar 

  2. Schneider MR, Michna H, Nishino Y, El Etreby MF: Antitumor activity of the progesterone antagonists ZK 98.299 and RU 486 in the hormone dependent MXT mammary tumor model of the mouse and the DMBA- and MNU-induced mammary tumor model of the rat. Eur J Cancer Clin Oncol 25: 691–701, 1989

    PubMed  Google Scholar 

  3. Klijn JGM, de Jong FH, Bakker GH, Lamberts SWJ, Rodenburg CJ, Alexieva-Figusch J: Antiprogestins, a new form of endocrine therapy for human breast cancer. Cancer Res 49: 2851–2856, 1989

    PubMed  Google Scholar 

  4. Dressier LG, Seamer L, Owens MA, Clark GM, McGuire WL: Evaluation of a modeling system for S-phase estimation in breast cancer by flow cytometry. Cancer Res 47: 5294–5302, 1987

    PubMed  Google Scholar 

  5. Scott RE, Hoerl BJ, Wille JJ, Florine DL, Krawisz BR, Kankatsu Y: Coupling of proadipocyte growth arrest and differentiation. II. A cell cycle model for the physiological control of cell proliferation. J Cell Biol 94: 400–405, 1982

    PubMed  Google Scholar 

  6. Wille JJ, Maercklein PB, Scott RE: Neoplastic transformation and defective control of cell proliferation and differentiation. Cancer Res 42: 5139–5146, 1982

    PubMed  Google Scholar 

  7. Michna H, Schneider MR, Nishino Y, El Etreby MF: The antitumor mechanism of progesterone antagonists is a receptor mediated antiproliferative effect by induction of terminal cell death. J Steroid Biochem 34: 447–453, 1989

    PubMed  Google Scholar 

  8. Briinner N, Bronzert D, Vindulov LL, Rygaard K, Spang-Thomsen M, Lippman ME: Effect on growth and cell cycle kinetics of estradiol and tamoxifen on MCF — 7 human breast cancer cells grown in vitro and in nude mice. Cancer Res 49: 1515–1520, 1989

    PubMed  Google Scholar 

  9. Clark GM, Dressier LG, Owens MA, Pounds G, Oldaker T, McGuire WL: Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry. N Engl J Med 320: 627–633, 1989

    PubMed  Google Scholar 

  10. McGuire WL, Dressier LG: Emerging impact of flow cytometry in predicting recurrence and survival in breast cancer patients. JNCI 75: 405–410, 1985

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Michna, H., Schneider, M., Nishino, Y. et al. Progesterone antagonists block the growth of experimental mammary tumors in G0/G1 . Breast Cancer Res Tr 17, 155–156 (1990). https://doi.org/10.1007/BF01806296

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01806296

Keywords

Navigation